23andMe customers requesting deletion of genetic data

Nearly 2 million 23andMe customers have requested deletion of their genetic data following bankruptcy and pending sale to Regeneron. Regeneron plans to use the data for drug discovery while upholding privacy practices. States have filed a lawsuit against the sale.